The economic impact of epilepsy;Impacto económico de la epilepsia

Revista de Neurologia

Volumn 39, Issue 5, 2004, Pages 450-453

  Pato Pato, Antonio ^a   Cimas Hernando, I ^a   Lorenzo Gonzalez J R ^a   Vadillo Olmo, F J ^b  

^a HOSPITAL POVISA   (Spain)

^b Unión Galega de Epilepsia   (Spain)

Author keywords

Economics; Epilepsy; Individual; Occupational activity; Pharmaceutical products; Psychological consequences; Society

Indexed keywords

ANTICONVULSIVE AGENT;

COST OF ILLNESS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ECONOMIC ASPECT; EPILEPSY; HEALTH SERVICE; HUMAN; PSYCHOLOGICAL ASPECT; REVIEW; SEIZURE; SOCIAL ASPECT; SPAIN;

EID: 8144220671     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3905.2004230     Document Type: Review

References (18)

1. Murray CJ, Lopez AD. Global comparative assessments in the health sector: disease burden, expenditures and intervention packages. Geneva: World Health Organization; 1994.
2. Eucare. European white paper on epilepsy. Bruselas: Eucare; 2002.
3. Kotsopoulos IA, Evers SM, Ament AJ, de Krom MC. Estimating the costs of epilepsy: An international comparison of epilepsy cost studies. Epilepsia 2001; 42: 634-40.
4. Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D. Uptake and cost of care for epilepsy, findings from a U.K. regional study. Epilepsia 1998; 39: 776-86.
5. Murray MI, Halpern MT, Leppik IE. Cost of refractory epilepsy in adults in the USA. Epilepsy Res 1996; 23: 139-48.
6. Cockerell OC, Hart YM, Sander JW, Shorvon SD. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population based studies. Epilepsy Res 1994; 18: 249-60.
7. Gessner U, Sagmeister M, Horisberger B. The economic impact of epilepsy in Switzerland. In Beran RG, Pachlatko C, eds. Cost of epilepsy: proceedings of the 20th International Epilepsy Congress. Wehr-Baden: Ciba-Geigy Verlag; 1993. p. 67-74.
8. Begley CE, Famulari M, Annegers JF, Lairson DR, Reynolds TF, Coan S. The cost of epilepsy in the United States: an estimate from population-based and survey data. Epilepsia 2000; 41: 342-52.
9. Swingler RJ, Davidson DL, Roberts RC, Moulding F. The cost of epilepsy in patients attending a specialist epilepsy service. Seizure 1994; 3: 115-20.
10. Silfvenius H. Economic costs of epilepsy-treatment benefits. Acta Neurol Scand 1988; 117: 136-54.
11. Blom J. The value for society of epidemiology and economics of epilepsy. In Beran RG, Pachlatko C, eds. Costs of epilepsy: proceedings of the 20th International Epilepsy Congress. Wehr/Baden: Ciba-Geigy Verlag; 1995. p. 55-65.
12. Banks GK, Regan KJ, Beran RG. The prevalence and direct costs of epilepsy in Australia. In Beran RG, Pachlatko C, eds. Costs of epilepsy: proceedings of the 20th International Epilepsy Congress. Wehr/Baden: Ciba-Geigy Verlag; 1995. p. 39-48.
13. Polder JJ, Meerding WJ, Koopmanschap MA, Bonneux L. Kosten van ziekten in Nederland 1994. Rotterdam: Instituut Maatschappelijke Gezondheidszorg; 1997
14. Argumosa A, Herranz JL. El coste económico de la epilepsia infantil en España. Rev Neurol 2000; 30: 104-8.
15. Grupos terapéuticos y principios activos de mayor consumo en el Sistema Nacional de Salud durante 2001. Información terapéutica del Sistema Nacional de Salud 2002; 26: 78-83.
16. Jacoby A. Impact of epilepsy on employment status: findings from a UK study of people with well-controlled epilepsy. Epilepsy Res 1995; 21: 125-32.
17. Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon SD. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994; 344: 918-21.
18. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: an European study. Epilepsia 1997; 38: 353-62.